Health
Common diabetes drug can reduce risk of major heart issues – TheHealthSite
SGLT2 inhibitors prescribed for diabetes can reduce the risk of heart conditions such as heart attack stroke and heart failure compared with placebo.
Drugs known as sodium-glucose cotransporter 2 (SGLT2) inhibitors are associated with a lower risk of major heart problems in patients with type 2 diabetes than dipeptidyl peptidase-4 (DPP-4) inhibitors, say, researchers. According to the study, published in the journal The BMJ, previous trials have shown that SGLT2 inhibitors can reduce the risk of heart conditions such as heart attack, stroke, and heart failure compared with placebo. But some of these trials had important limitations, making it…
-
Noosa News23 hours agoMan dies after stabbing in inner-city unit
-
Noosa News21 hours agoBrisbane man, 39, dies after stabbing at inner city home in early morning attack, prompting investigation
-
General23 hours agoMiners injured at GM3’s Appin Mine after being buried by coal
-
General17 hours agoDonald Trump and the ghost of Al Capone • Inside Story